About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

OncoTherapy Science, Inc.(4564) Historical

4564
TSE Growth
OncoTherapy Science, Inc.
24
JPY
0
(0.00%)
Dec 23, 3:00 pm JST
0.15
USD
Dec 23, 1:00 am EST
Result
PTS
outside of trading hours
24.9
Dec 23, 3:04 pm JST
Summary Chart Historical News Financial Result
52 Week High Aug 1, 2024
64 JPY
52 Week Low May 13, 2024
15 JPY
Yearly High Aug 1, 2024
64 JPY
Yearly Low May 13, 2024
15 JPY

Latest Weekly Price

Date Opening High Low Closing Price Change % Volume
Dec 23, 2024 25 26 24 24 0 0.00% 6,053,800

Weekly Margin Balance

Date Closing Price % Avg. Price Volume Sell Positions(Shares) Buy Positions(Shares) Margin Ratio
Dec 20, 2024 24 -22.58% 27 31,408,300
Dec 13, 2024 31 +3.33% 30 21,230,800 3,757,800 18,329,900 4.88
Dec 6, 2024 30 -3.23% 30 21,514,100 3,889,900 19,032,900 4.89
Nov 29, 2024 31 -3.13% 31 25,368,100 3,650,200 19,274,000 5.28
Nov 22, 2024 32 +6.67% 30 20,184,600 4,167,900 18,555,900 4.45
Nov 15, 2024 30 -6.25% 30 15,920,000 4,090,800 19,054,900 4.66
Nov 8, 2024 32 0.00% 32 10,567,400 4,365,900 19,706,900 4.51
Nov 1, 2024 32 +6.67% 31 16,112,900 4,519,900 19,283,400 4.27
Oct 25, 2024 30 -3.23% 31 14,898,500 4,167,600 19,777,500 4.75
Oct 18, 2024 31 -8.82% 32 14,232,400 4,303,900 20,850,500 4.84
Oct 11, 2024 34 -10.53% 38 28,410,800 4,911,900 21,903,200 4.46
Oct 4, 2024 38 -5.00% 38 12,787,600 3,772,500 20,752,000 5.50
Sep 27, 2024 40 0.00% 38 16,562,300 3,936,200 21,195,900 5.38
Sep 20, 2024 40 +8.11% 36 25,938,400 4,355,000 20,642,700 4.74
Sep 13, 2024 37 -9.76% 39 32,367,000 4,199,400 22,137,300 5.27
Sep 6, 2024 41 -8.89% 43 51,131,500 4,811,200 23,312,200 4.85
Aug 30, 2024 45 -11.76% 50 68,716,800 4,158,400 23,374,300 5.62
Aug 23, 2024 51 +4.08% 52 88,654,000 4,722,800 24,262,900 5.14
Aug 16, 2024 49 0.00% 50 76,486,100 5,306,800 23,785,500 4.48
Aug 9, 2024 49 -12.50% 49 176,347,300 5,983,800 19,106,200 3.19